Effective Jan. 4, 2018, the North Carolina Medicaid and NC Health Choice (NCHC) programs will cover aprepitant injectable emulsion (Cinvanti), for intravenous use in the Physician’s Drug Program (PDP) when billed with HCPCS code J3490 - Unclassified drugs.
Cinvanti is available as 130 mg in a single-dose vial. It is approved by the Food and Drug Administration (FDA) for adults, in combination with other antiemetic agents, for the prevention of: